Life Sciences Tools and Services
Company Overview of Lifeline Cell Technology, LLC
Lifeline Cell Technology, LLC develops, manufactures, and markets human cells, cell culture media, and reagents for cell culture research applications. The company offers skin test products, cryopreservation solutions, fibroblast systems/stem cell products, hematopoietic systems, hepatocyte products, keratinocyte systems, pulmonary, RNA products, special edition cells, stain kits, and subculture reagents, and custom products and services. It also provides bladder, corneal epithelial, endothelial, mammary, melanocyte, prostate, renal, smooth muscle, and human and non human stem cell systems. The company’s custom cell cultural media products include molecular biology reagents, protein purifica...
5950 Priestly Drive
Carlsbad, CA 92008
Founded in 2001
Key Executives for Lifeline Cell Technology, LLC
Co-Founder and Director of Quality Control
Chief Financial Officer and Managing Member
President of International Stem Cell Corporation
Compensation as of Fiscal Year 2014.
Lifeline Cell Technology, LLC Key Developments
Lifeline Cell Technology Expands Asian Distribution Network
Jul 16 14
International Stem Cell Corporation announced that its subsidiary, Lifeline Cell Technology, has expanded its sales network by adding a number of new distributors in Asia and Oceania. Lifeline Cell Technology (LCT) has expanded its overseas network by adding new distributors in several fast-growing territories including Korea, Taiwan, Australia, New Zealand and India. LCT develops, manufactures and commercializes over 130 human cell culture products. These products include frozen human adult or primary cells, adult stem cells and the reagents (called media) needed to grow, maintain and differentiate such cells. These human cell-based products are used by research scientists in pharmaceutical, academic and government research organizations to study human diseases and basic cell biology. LCT's products provide value and quality by eliminating the need for scientists to source their own cells or develop their own media. Strict quality assurance ensures a high level of consistency and standardization, which along with a high level of customer service, makes LCT's products the first choice for many scientists.
Lifeline Cell Technology, LLC Products to be Added to Fisher Scientific International Inc.'s Catalogs
Oct 25 12
International Stem Cell Corporation announced that Lifeline Cell Technology, LLC will begin selling products through Fisher Scientific International Inc.'s online catalogue as an Encompass Preferred Supplier. Typically large pharmaceutical companies buy research supplies and products using preferred supplier agreements. Their third party e-catalog sales have grown from $26 million in 2006 to $424 million in 2011 and represent a promising new sales channel for Lifeline Cell Technology's cell and media products. By working with Fisher Scientific, LCT will be able to reach many more customers that the company would otherwise not be able to reach.
Lifeline Cell Technology, LLC Announces Unaudited Revenue Results for the Six Months Ended June 30, 2012
Aug 9 12
Lifeline Cell Technology, LLC announced unaudited revenue results for the six months ended June 30, 2012. For the six months ended June 30, 2012, LCT generated revenue of $1.06 million compared to $0.97 million for same period in 2011.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|